SEARCH

SEARCH BY CITATION

References

  • Aguirre A., Shoji K. F., Saez J. C., Henriquez M. and Quest A. F. (2013) FasL-triggered death of Jurkat cells requires caspase 8-induced, ATP-dependent cross-talk between Fas and the purinergic receptor P2X(7). J. Cell. Physiol. 228, 485493.
  • Apolloni S., Montilli C., Finocchi P. and Amadio S. (2009) Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events. FEBS J. 276, 354364.
  • Burnstock G. (2008) Purinergic signalling and disorders of the central nervous system. Nat. Rev. Drug Discov. 7, 575590.
  • Casanovas A., Hernandez S., Tarabal O., Rossello J. and Esquerda J. E. (2008) Strong P2X4 purinergic receptor-like immunoreactivity is selectively associated with degenerating neurons in transgenic rodent models of amyotrophic lateral sclerosis. J. Comp. Neurol. 506, 7592.
  • Casha S., Yu W. R. and Fehlings M. G. (2005) FAS deficiency reduces apoptosis, spares axons and improves function after spinal cord injury. Exp. Neurol. 196, 390400.
  • D'Ambrosi N., Finocchi P., Apolloni S., Cozzolino M., Ferri A., Padovano V., Pietrini G., Carri M. T. and Volonte C. (2009) The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis. J. Immunol. 183, 46484656.
  • Demjen D., Klussmann S., Kleber S. et al. (2004) Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury. Nat. Med. 10, 389395.
  • Diaz-Hernandez M., Diez-Zaera M., Sanchez-Nogueiro J., Gomez-Villafuertes R., Canals J. M., Alberch J., Miras-Portugal M. T. and Lucas J. J. (2009) Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration. FASEB J. 23, 18931906.
  • Donnelly-Roberts D. L., Namovic M. T., Han P. and Jarvis M. F. (2009) Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors. Br. J. Pharmacol. 157, 12031214.
  • Estevez A. G., Spear N., Manuel S. M., Barbeito L., Radi R. and Beckman J. S. (1998) Role of endogenous nitric oxide and peroxynitrite formation in the survival and death of motor neurons in culture. Prog. Brain Res. 118, 269280.
  • Estevez A. G., Crow J. P., Sampson J. B., Reiter C., Zhuang Y., Richardson G. J., Tarpey M. M., Barbeito L. and Beckman J. S. (1999) Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science 286, 24982500.
  • Franco M. C., Ye Y., Refakis C. A. et al. (2013) Nitration of Hsp90 induces cell death. Proc. Natl Acad. Sci. USA 110, E1102E1111.
  • Gandelman M., Peluffo H., Beckman J. S., Cassina P. and Barbeito L. (2010) Extracellular ATP and the P2X7 receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis. J. Neuroinflammation 7, 33.
  • Genovese T., Melani A., Esposito E. et al. (2010) Selective adenosine A(2a) receptor agonists reduce the apoptosis in an experimental model of spinal cord trauma. J. Biol. Regul. Homeost. Agents 24, 7386.
  • Handy R. L., Wallace P., Gaffen Z. A., Whitehead K. J. and Moore P.K. (1995) The antinociceptive effect of 1-(2-trifluoromethylphenyl) imidazole (TRIM), a potent inhibitor of neuronal nitric oxide synthase in vitro, in the mouse. Br. J. Pharmacol. 116, 23492350.
  • Henderson C. E., Bloch-Gallego E. and Camu W. (1995) Purification and culture of embryonic motor neurons: Neural cell culture: a practical approach. IRL Press, Oxford.
  • Hewinson J. and Mackenzie A. B. (2007) P2X(7) receptor-mediated reactive oxygen and nitrogen species formation: from receptor to generators. Biochem. Soc. Trans. 35, 11681170.
  • Jacobson K. A. and Gao Z. G. (2006) Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discov. 5, 247264.
  • Jun D. J., Kim J., Jung S. Y. et al. (2007) Extracellular ATP mediates necrotic cell swelling in SN4741 dopaminergic neurons through P2X7 receptors. J. Biol. Chem. 282, 3735037358.
  • Koles L., Furst S. and Illes P. (2005) P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnesses. Drug News Perspect. 18, 85101.
  • Locatelli F., Corti S., Papadimitriou D. et al. (2007) Fas small interfering RNA reduces motoneuron death in amyotrophic lateral sclerosis mice. Ann. Neurol. 62, 8192.
  • Martin L. J., Chen K. and Liu Z. (2005) Adult motor neuron apoptosis is mediated by nitric oxide and Fas death receptor linked by DNA damage and p53 activation. J. Neurosci. 25, 64496459.
  • Matsushita K., Wu Y., Qiu J., Lang-Lazdunski L., Hirt L., Waeber C., Hyman B. T., Yuan J. and Moskowitz M. A. (2000) Fas receptor and neuronal cell death after spinal cord ischemia. J. Neurosci. 20, 68796887.
  • Matute C., Torre I., Perez-Cerda F. et al. (2007) P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J. Neurosci. 27, 95259533.
  • Melani A., Turchi D., Vannucchi M. G., Cipriani S., Gianfriddo M. and Pedata F. (2005) ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia. Neurochem. Int. 47, 442448.
  • Pehar M., Vargas M. R., Cassina P., Barbeito A. G., Beckman J. S. and Barbeito L. (2005) Complexity of astrocyte-motor neuron interactions in amyotrophic lateral sclerosis. Neurodegener Dis. 2, 139146.
  • Pehar M., Vargas M. R., Robinson K. M., Cassina P., England P., Beckman J. S., Alzari P. M. and Barbeito L. (2006) Peroxynitrite transforms nerve growth factor into an apoptotic factor for motor neurons. Free Radic. Biol. Med. 41, 16321644.
  • Pehar M., Vargas M. R., Robinson K. M., Cassina P., Diaz-Amarilla P. J., Hagen T. M., Radi R., Barbeito L. and Beckman J. S. (2007) Mitochondrial superoxide production and nuclear factor erythroid 2-related factor 2 activation in p75 neurotrophin receptor-induced motor neuron apoptosis. J. Neurosci. 27, 77777785.
  • Peng W., Cotrina M. L., Han X. et al. (2009) Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc. Natl Acad. Sci. USA 106, 1248912493.
  • Phillis J. W., O'Regan M. H. and Perkins L. M. (1993) Adenosine 5′-triphosphate release from the normoxic and hypoxic in vivo rat cerebral cortex. Neurosci. Lett. 151, 9496.
  • Piccini A., Carta S., Tassi S., Lasiglie D., Fossati G. and Rubartelli A. (2008) ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc. Natl Acad. Sci. USA 105, 80678072.
  • Raoul C., Henderson C. E. and Pettmann B. (1999) Programmed cell death of embryonic motoneurons triggered through the Fas death receptor. J. Cell Biol. 147, 10491062.
  • Raoul C., Estevez A. G., Nishimune H., Cleveland D. W., deLapeyriere O., Henderson C. E., Haase G. and Pettmann B. (2002) Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations. Neuron 35, 10671083.
  • Raoul C., Buhler E., Sadeghi C., Jacquier A., Aebischer P., Pettmann B., Henderson C. E. and Haase G. (2006) Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL. Proc. Natl Acad. Sci. USA 103, 60076012.
  • Robinson K. M., Morre J. T. and Beckman J. S. (2004) Triuret: a novel product of peroxynitrite-mediated oxidation of urate. Arch. Biochem. Biophys. 423, 213217.
  • Ryu J. K. and McLarnon J. G. (2008) Block of purinergic P2X(7) receptor is neuroprotective in an animal model of Alzheimer's disease. NeuroReport 19, 17151719.
  • Sahawneh M. A., Ricart K. C., Roberts B. R. et al. (2010) Cu, Zn-superoxide dismutase increases toxicity of mutant and zinc-deficient superoxide dismutase by enhancing protein stability. J. Biol. Chem. 285, 3388533897.
  • Sakurai M., Hayashi T., Abe K., Sadahiro M. and Tabayashi K. (1998) Delayed selective motor neuron death and fas antigen induction after spinal cord ischemia in rabbits. Brain Res. 797, 2328.
  • Santos C. X., Anjos E. I. and Augusto O. (1999) Uric acid oxidation by peroxynitrite: multiple reactions, free radical formation, and amplification of lipid oxidation. Arch. Biochem. Biophys. 372, 285294.
  • Soon C. P., Donnelly P. S., Turner B. J. et al. (2011) Diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (CuII(atsm)) protects against peroxynitrite-induced nitrosative damage and prolongs survival in amyotrophic lateral sclerosis mouse model. J. Biol. Chem. 286, 4403544044.
  • Sperlagh B., Vizi E. S., Wirkner K. and Illes P. (2006) P2X7 receptors in the nervous system. Prog. Neurobiol. 78, 327346.
  • Ugolini G., Raoul C., Ferri A., Haenggeli C., Yamamoto Y., Salaün D., Henderson C. E., Kato A. C., Pettmann B. and Hueber A. O. (2003) Fas/tumor necrosis factor receptor death signaling is required for axotomy-induced death of motoneurons in vivo. J. Neurosci. 23, 85268531.
  • Wang X., Arcuino G., Takano T. et al. (2004) P2X7 receptor inhibition improves recovery after spinal cord injury. Nat. Med. 10, 821827.
  • Wiese S., Jablonka S., Holtmann B., Orel N., Rajagopal R., Chao M. V. and Sendtner M. (2007) Adenosine receptor A2A-R contributes to motoneuron survival by transactivating the tyrosine kinase receptor TrkB. Proc. Natl Acad. Sci. USA 104, 1721017215.
  • Wu A. S., Kiaei M., Aguirre N., Crow J. P., Calingasan N. Y., Browne S. E. and Beal M. F. (2003) Iron porphyrin treatment extends survival in a transgenic animal model of amyotrophic lateral sclerosis. J. Neurochem. 85, 142150.
  • Yiangou Y., Facer P., Durrenberger P., Chessell I. P., Naylor A., Bountra C., Banati R. R. and Anand P. (2006) COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol. 6, 12.